COVID-19 and generalized Myasthenia Gravis exacerbation: A case report

• MG treatment in the context of COVID-19 should be tailored to the patient. • Patient’s respiratory status should be closely monitored. • Concomitant COVID-19 and MG has a variable response to treatment.

Detalles Bibliográficos
Autores principales: Singh, Shivangi, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316067/
https://www.ncbi.nlm.nih.gov/pubmed/32634699
http://dx.doi.org/10.1016/j.clineuro.2020.106045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316067/
https://www.ncbi.nlm.nih.gov/pubmed/32634699
http://dx.doi.org/10.1016/j.clineuro.2020.106045

Ejemplares similares